...
首页> 外文期刊>Powder diffraction >Quantitative measurement of crystalline impurity in a pharmaceutical tablet by X-ray powder diffraction and method validation
【24h】

Quantitative measurement of crystalline impurity in a pharmaceutical tablet by X-ray powder diffraction and method validation

机译:X射线粉末衍射定量测定药物片剂中结晶杂质的方法验证

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A powder X-ray diffraction method was developed and validated to measure the crystalline impurity 4-(5-cyclopentyloxy-carbonylamino-l-methyl-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfon-ylbenzamide hydrate in a pharmaceutical tablet ranging from 0.6 to 3% (w/w). The calibration plot was found to be linear with a correlation coefficient (γ~2) of 0.996, and was reproducible among operators. The detection limit was determined to be 0.6% with a signal-to-noise ratio of 3:1. The quanti-tation limit was determined to be 1% with a signal-to-noise ratio of 5:1. Instrument precision at the quantitation limit was 5.8%. Method precision was 6.1% at the quantitation limit and 7.4% at the detection limit. Intermediate precision at the quantitation limit was 7.3% during a 6-month study. Accuracy measurements using crystalline impurity standards prepared in an excipient mixture ranged from 89.3 to 105.5%. Accuracy measurements using tablets containing spiked quantities of crystalline impurity ranged from 72.0 to 92.7%. Accuracy measurements using spiked tablets were complicated because the crystalline impurity was lost during the manufacturing process and a correction factor was used. Ruggedness was assessed by evaluating repetitive assay, repetitive packing, sample packing, and sample stability. Repetitive assays show the exposure of standards to a relative humidity in excess of 57% caused displacement error because of an increase in sample volume and a peak-position shift. Repetitive-packing studies show the analyte was extracted from the sample at a low relative humidity because of a static-charge induction. Sample-packing studies show that two subjective packing techniques were equivalent, and that under- and over-packing samples cause changes in sample density which would not affect results within +-16%. Sample-stability studies show that the quanti-tation-limit standard was stable as long as the sample was exposed to a relative humidity below 57%.
机译:开发了粉末X射线衍射方法并进行了验证,以测定药物片剂中的结晶杂质4-(5-环戊氧基-羰基氨基-1-甲基-吲哚-3-基甲基)-3-甲氧基-甲苯基磺酰基苯甲酰胺水合物从0.6%到3%(w / w)。发现该标定图是线性的,相关系数(γ〜2)为0.996,并且在操作员之间是可重现的。检出限确定为0.6%,信噪比为3:1。定量限为1%,信噪比为5:1。定量限的仪器精度为5.8%。在定量下限时方法精度为6.1%,在检测下限时方法精度为7.4%。在为期6个月的研究中,定量限的中间精密度为7.3%。使用在赋形剂混合物中制备的结晶杂质标准液的准确度测量范围为89.3至105.5%。使用含有尖峰杂质的片剂的准确度测量范围为72.0%至92.7%。使用加标片剂的精度测量非常复杂,因为在制造过程中会损失结晶杂质,并使用校正因子。通过评估重复测定,重复包装,样品包装和样品稳定性来评估耐用性。重复测定表明,由于样品体积的增加和峰位偏移,标准液暴露于相对湿度超过57%时会引起位移误差。重复包装研究表明,由于产生了静电荷,因此在较低的相对湿度下从样品中提取了分析物。样品包装研究表明,两种主观包装技术是等效的,并且包装不足和包装过量会导致样品密度发生变化,但不会影响结果在+ -16%之内。样品稳定性研究表明,只要样品暴露在低于57%的相对湿度下,定量限标准品就稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号